Why Tilray’s (TSX:TLRY) Stock Price Soared 7% Today

Here’s the key reason why Tilray Inc.’s (TSX:TLRY)(NASDAQ:TLRY) stock price soared today. Let’s also find out why it might continue rallying in the long term.

| More on:
grow dividends

Image source: Getty Images

What happened?

Tilray’s (TSX:TLRY)(NASDAQ:TLRY) share price surged by nearly 7% to $17.68 per share this afternoon. These sharp gains in the popular Canadian pot stock came after the company highlighted its new investment in the American cannabis firm MedMen Enterprises (CNSX:MMEN).

So what?

On Wednesday, Tilray, in a press release, said that it has acquired most of the senior secured convertible notes of MedMen from funds affiliated with Gotham Green Partners. After converting these notes into stocks — upon getting necessary regulatory approvals, Tilray is likely to have minority stakes but still a significant equity position in MedMen.

Tilray is a Nanaimo-based cannabis firm that mainly focuses on the research, cultivation, processing, and distribution of various medical cannabis products to pharmaceutical distributors. Its key markets include Canada, the United States, Europe, Australia, and Latin America.

Tilray’s latest investment in MedMen could potentially help its footprints grow fast in the U.S. market. It could be the primary reason why Tilray stock rallied after the news came out.

Now what?

Tilray’s recent merger with Aphria made it the world’s largest cannabis company. The deal also clearly reflected Tilray’s aggressive expansion plan for the international market.

MedMen is a well-known American cannabis retailer. It currently operates nearly 25 retail locations and holds 21 licences. While MedMen’s expansion in the U.S. could be subject to several factors, including federal legalization of cannabis, the company plans to expand its footprints in the international market before that. Considering these factors, Tilray’s investment in MedMen could prove to be a key step in helping it grow fast in the U.S. market once federal legalization is approved.

I believe Tilray’s latest move to invest in MedMen could pay off well in the long term and help it grow faster than its peers. That’s why long-term growth investors may want to consider adding TLRY stock to their portfolio right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Canopy Growth Stock Worth Buying?

Canopy Growth stock (TSX:WEED) made a big move to consolidate its shares, but will this help the company move forward?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »